OTTAWA, Ontario, June 8 /PRNewswire/ -- Bridgewater Systems (TSX: BWC), the mobile personalization company, will unveil an innovative solution that personalizes the mobile experience and prevents mobile bill shock at a press conference at CommunicAsia on June 17 , 2009 in Singapore.

- Attend Bridgewater's press conference on June 17th in press conference room K at 10:30 am (GMT + 8:00) to hear David Sharpley, Senior Vice President of Marketing and Product Management, describe the company's new mobile personalization solution and see live demonstrations. Apple iPod touches will be given away by raffle to press and analysts at the event.

CHICAGO and FRANKFURT, June 8 /PRNewswire/ --

- Strategic Commitment to Deutsche Boerse's New Offering for European Blue Chips Scheduled Q4/2009

RTS Realtime Systems Group, a leading trading solutions provider, announced today that it will launch a gateway to connect directly to Deutsche Boerse's pan-European blue chip trading platform, Xetra(R) International Market (XIM), scheduled for launch in the fourth quarter of 2009.

The new Deutsche Boerse platform, based on the exchange's Xetra electronic trading platform, will enable participants in 18 different countries to extend seamlessly their trading operations to include highly liquid European equities from across those countries, including all Dow Jones EURO STOXX 50(R) stocks.

Do you have what it takes to be Scientific Blogging's alpha geek? Well it’s time put your geek where your mouth is…IF YOU CAN!

But first a warning: yes, you could Google for these answers, but then, deep down, you’ll know you’re a bad person. Then again, you might win a free Geeks’ Guide to World Domination. So you’ll have to balance total loss of self worth with free geek schwag. It’s up to you.

Email your answers to geekoff@gmail.com. DON'T COMMENT YOUR ANSWERS or you will allow slackers to water down the winner’s pool, thus decreasing your chances of receiving said geek schwag (and you’ll get moderated,

VANCOUVER, June 8 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced that it has elected its 2009 Board of Directors at its recent Annual General Meeting. The six-member Board consists of: Dr. James McEwen (Chairman), Dr. Heiner Dreismann, Mr. Jim Heppell, Mr. Amos Michelson, Dr. Bradley Popovich and Mr. Patrick Terry.

WELLESLEY HILLS, Massachusetts, June 8 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. (Finn) announced today that he has received a statement from Ludwig Institute of Cancer Research Ltd., Brussels Branch. The statement is quoted in its entirety below.

Prospect Therapeutics' lead product candidate, GCS-100, is a carbohydrate molecule which inhibits the activity of Galectin-3, a protein found in high concentration in a broad range of human cancers. Prospect reported that GCS-100 could induce apoptosis of cancer cells and that clinical trial results indicated that reduction in leukemic cell number could be obtained without severe side effects.

HAIFA, Israel, June 8 /PRNewswire/ --

- ORL Succeeds in Reducing Cost From Original $670 Million by Leveraging Macro-Economic Environment Unit, due to be Operational by Early 2012, is Expected to Process 25,000 Barrels per day Unit Expected to Increase ORL's Nelson Complexity Index From Current 7.4 to 9.0

HAIFA, Israel, June 8 /PRNewswire/ --

BOSTON and CAMBRIDGE, England, June 8 /PRNewswire/ --

- New EM300 Series first ZigBee system-on-chips (SoCs) based on the 32-bit ARM Cortex-M3 processor

Ember, a leader in wireless networking technology, today unveiled the EM300 Series, its next-generation ZigBee chip family that packs the industry's highest wireless networking performance and application code space into the lowest power-consuming chip set.

HELSINKI, June 8 /PRNewswire/ -- Ipsat Therapies announced today that oral P1A beta-lactamase met all end-points and provided protection for the normal gastrointestinal microflora in a phase 1 study in healthy subjects receiving intravenous piperacillin/tazobactam for 5 days.

Ipsat P1A

P1A is the most advanced of Ipsat's portfolio of beta-lactamases. It is administered orally and designed to inactivate the residual amounts of certain beta-lactam antibiotics excreted into the patients' gastrointestinal tract, after intravenous administration of these antibiotics for serious infections, and to reduce the transmission of resistant bacteria.

The Phase I study,

PARIS, June 8 /PRNewswire/ --

- Survey Reveals Most Europeans Know so Little About Parkinson's They Would be Unlikely to Recognise its Early Symptoms and See Their Doctor for Prompt Diagnosis and Treatment

NOORDIJK, The Netherlands, June 8 /PRNewswire/ --

- Novel Mobile Service AllAroundMe Uses Smart Navigation Technology to Provide Personalised Information on Shopping, Dining and Events - Wherever you are

With its novel mobile phone service AllAroundMe, launched in The Netherlands on 8 June, Dutch company Mobzili provides location-based information on shopping, entertainment, tourism and public transportation by combining satellite and telecommunication technology with the latest and greatest local information. AllAroundMe technology development was supported by the European Space Agency (ESA) Technology Transfer Programme Office through its Business Incubation Centre in Noordwijk, The Netherlands.